The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.

Viridian reports $24.7 million Lumvoa revenue in launch quarter

Nov 8, 2026 03:02 (24h ago)

Verifying

Viridian reported $24.7 million in Lumvoa net product revenue during its launch quarter.
More than 100 patients had completed at least one Lumvoa infusion by September 30.
CMS assigned Lumvoa a permanent J-code effective January 1, 2027.